Karthick Vishwanathan
11PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 10, 2025
A quantitative model-based approach for adavosertib dose selection in patients with uterine serous carcinoma.Shankar Lanke, Kowser Miah, Damilola Olabode
|Apr 28, 2025
Population Pharmacokinetics of Osimertinib in Patients With Non-Small Cell Lung Cancer.Martin Johnson, Yu-Wei Lin, Henning Schmidt
|Feb 15, 2022
Acalabrutinib CYP3A-mediated drug-drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy.Buyun Chen, Diansong Zhou, Hua Wei
|Dec 13, 2021
Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment.Yan Xu, Raquel Izumi, Helen Nguyen
|Sep 17, 2021
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignancies.Helena Edlund, Núria Buil-Bruna, Karthick Vishwanathan
|Jul 29, 2021
Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam.Song Ren, Karthick Vishwanathan, Mireille Cantarini
Pageof 2
